{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:52:36Z","timestamp":1780451556638,"version":"3.54.1"},"reference-count":42,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministry of Education, Universities and Research","doi-asserted-by":"publisher","award":["ex60%"],"award-info":[{"award-number":["ex60%"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ferring Pharmaceuticals A\/S","award":["grant to BB"],"award-info":[{"award-number":["grant to BB"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Endometrial mesenchymal stromal cells (E-MSCs) extensively contribute to the establishment and progression of endometrial ectopic lesions through formation of the stromal vascular tissue, and support to its growth and vascularization. As E-MSCs lack oestrogen receptors, endometriosis eradication cannot be achieved by hormone-based pharmacological approaches. Quinagolide is a non-ergot-derived dopamine receptor 2 agonist reported to display therapeutic effects in in vivo models of endometriosis. In the present study, we isolated E-MSCs from eutopic endometrial tissue and from ovarian and peritoneal endometriotic lesions, and we tested the effect of quinagolide on their proliferation and matrix invasion ability. Moreover, the effect of quinagolide on E-MSC endothelial differentiation was assessed in an endothelial co-culture model of angiogenesis. E-MSC lines expressed dopamine receptor 2, with higher expression in ectopic than eutopic ones. Quinagolide inhibited the invasive properties of E-MSCs, but not their proliferation, and limited their endothelial differentiation. The abrogation of the observed effects by spiperone, a dopamine receptor antagonist, confirmed specific dopamine receptor activation. At variance, no involvement of VEGFR2 inhibition was observed. Moreover, dopamine receptor 2 activation led to downregulation of AKT and its phosphorylation. Of interest, several effects were more prominent on ectopic E-MSCs with respect to eutopic lines. Together with the reported effects on endometrial and endothelial cells, the observed inhibition of E-MSCs may increase the rationale for quinagolide in endometriosis treatment.<\/jats:p>","DOI":"10.3390\/ijms23031775","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T11:35:17Z","timestamp":1643974517000},"page":"1775","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Quinagolide Treatment Reduces Invasive and Angiogenic Properties of Endometrial Mesenchymal Stromal Cells"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3153-9271","authenticated-orcid":false,"given":"Corinne","family":"Iampietro","sequence":"first","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, Universit\u00e0 degli Studi di Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5973-5007","authenticated-orcid":false,"given":"Alessia","family":"Brossa","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, Universit\u00e0 degli Studi di Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-6750","authenticated-orcid":false,"given":"Stefano","family":"Canosa","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, Department of Surgical Sciences, Universit\u00e0 degli Studi di Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Tritta","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, Universit\u00e0 degli Studi di Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn E.","family":"Croston","sequence":"additional","affiliation":[{"name":"EicOsis, Davis, CA 95616, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten Michael","family":"Reinheimer","sequence":"additional","affiliation":[{"name":"Reinheimer.Expert ApS, 2300 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Bonelli","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, Universit\u00e0 degli Studi di Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7734-4499","authenticated-orcid":false,"given":"Andrea Roberto","family":"Carosso","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, Department of Surgical Sciences, Universit\u00e0 degli Studi di Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4390-9428","authenticated-orcid":false,"given":"Gianluca","family":"Gennarelli","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, Department of Surgical Sciences, Universit\u00e0 degli Studi di Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0563-0071","authenticated-orcid":false,"given":"Stefano","family":"Cosma","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, Department of Surgical Sciences, Universit\u00e0 degli Studi di Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Benedetto","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, Department of Surgical Sciences, Universit\u00e0 degli Studi di Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5797-3722","authenticated-orcid":false,"given":"Alberto","family":"Revelli","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, S. Anna Hospital, Department of Surgical Sciences, Universit\u00e0 degli Studi di Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3663-5134","authenticated-orcid":false,"given":"Benedetta","family":"Bussolati","sequence":"additional","affiliation":[{"name":"Department of Molecular Biotechnology and Health Sciences, Universit\u00e0 degli Studi di Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0889-8545(21)00136-4","article-title":"Clinical Presentation and Diagnosis of Endometriosis","volume":"16","author":"Galle","year":"1989","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(04)17403-5","article-title":"Endometriosis","volume":"364","author":"Giudice","year":"2004","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1530\/JOE-20-0106","article-title":"Androgens, oestrogens and endometrium: A fine balance between perfection and pathology","volume":"246","author":"Gibson","year":"2020","journal-title":"J. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.fertnstert.2005.02.056","article-title":"Putative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycle","volume":"84","author":"Schwab","year":"2005","journal-title":"Fertil. Steril."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Masuda, H., Matsuzaki, Y., Hiratsu, E., Ono, M., Nagashima, T., Kajitani, T., Arase, T., Oda, H., Uchida, H., and Asada, H. (2010). Stem Cell-Like Properties of the Endometrial Side Population: Implication in Endometrial Regeneration. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010387"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1095\/biolreprod.116.141325","article-title":"Endometrial Mesenchymal Stem\/Stromal Cells, Their Fibroblast Progeny in Endometriosis, and More","volume":"94","author":"Gargett","year":"2016","journal-title":"Biol. Reprod."},{"key":"ref_7","first-page":"137","article-title":"Endometrial stem\/progenitor cells: The first 10 years","volume":"22","author":"Gargett","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/REP-07-0428","article-title":"Characterization of clonogenic stromal cells isolated from human endometrium","volume":"135","author":"Dimitrov","year":"2008","journal-title":"Reproduction"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1095\/biolreprod.108.075226","article-title":"Isolation and Culture of Epithelial Progenitors and Mesenchymal Stem Cells from Human Endometrium1","volume":"80","author":"Gargett","year":"2009","journal-title":"Biol. Reprod."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Cervell\u00f3, I., Mas, A., Gil-Sanchis, C., Peris, L., Faus, A., Saunders, P., Critchley, H.O.D., and Sim\u00f3n, C. (2011). Reconstruction of Endometrium from Human Endometrial Side Population Cell Lines. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021221"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.fertnstert.2010.09.064","article-title":"Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model","volume":"95","author":"Kao","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1093\/humrep\/dem265","article-title":"Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium","volume":"22","author":"Schwab","year":"2007","journal-title":"Hum. Reprod."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.3727\/096368911X637362","article-title":"A Novel Marker of Human Endometrial Mesenchymal Stem-Like Cells","volume":"21","author":"Masuda","year":"2012","journal-title":"Cell Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humrep\/det457","article-title":"ESHRE guideline: Management of women with endometriosis","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum. Reprod."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/1933719113503405","article-title":"Endometrial adult\/progenitor stem cells: Pathogenetic theory and new antiangiogenic approach for endometriosis therapy","volume":"21","author":"Pittatore","year":"2013","journal-title":"Reprod. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/humrep\/13.6.1686","article-title":"Vascular endothelial growth factor (VEGF) in endometriosis","volume":"13","author":"Donnez","year":"1998","journal-title":"Hum. Reprod."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/humupd\/6.1.45","article-title":"Vascular endothelial growth factor and endometriotic angiogenesis","volume":"6","author":"McLaren","year":"2000","journal-title":"Hum. Reprod. Updat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/rep.1.01110","article-title":"The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions","volume":"132","author":"Bourlev","year":"2006","journal-title":"Reproduction"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-020-01856-8","article-title":"Biological characteristics of endometriotic mesenchymal stem cells isolated from ectopic lesions of patients with endometriosis","volume":"11","author":"Liu","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.fertnstert.2012.08.003","article-title":"Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis","volume":"98","author":"Moggio","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1242\/jcs.053124","article-title":"Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2","volume":"122","author":"Sinha","year":"2009","journal-title":"J. Cell Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1159\/000452796","article-title":"The Non-Ergot Derived Dopamine Agonist Quinagolide as an Anti-Endometriotic Agent","volume":"82","author":"Akyol","year":"2016","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/eje.1.02075","article-title":"Quinagolide\u2014A valuable treatment option for hyperprolactinaemia","volume":"154","author":"Barlier","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"ref_25","first-page":"187","article-title":"Angiogenic properties of endometrial mesenchymal stromal cells in endothelial co-culture: An in vitro model of endometriosis","volume":"23","author":"Canosa","year":"2017","journal-title":"Mol. Hum. Reprod."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/87895","article-title":"The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor\/vascular endothelial growth factor","volume":"7","author":"Basu","year":"2001","journal-title":"Nat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/molehr\/gau025","article-title":"Potential role of endometrial stem\/progenitor cells in the pathogenesis of early-onset endometriosis","volume":"20","author":"Gargett","year":"2014","journal-title":"Mol. Hum. Reprod."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation","volume":"356","author":"Schade","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1012884214668","article-title":"Quinagolide in the management of prolactinoma","volume":"3","author":"Schultz","year":"2000","journal-title":"Pituitary"},{"key":"ref_30","first-page":"P251","article-title":"Differential effects of dopamine agonists at D2S and 5HT2B receptors","volume":"19","author":"Igbokwe","year":"2009","journal-title":"Endocr. Abstr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.fertnstert.2010.10.024","article-title":"Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia","volume":"95","author":"Abad","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/humrep\/deaa337","article-title":"Use of dopamine agonists to target angiogenesis in women with endometriosis","volume":"36","author":"Pellicer","year":"2021","journal-title":"Hum. Reprod."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/REP-11-0223","article-title":"The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis","volume":"142","author":"Ferrero","year":"2011","journal-title":"Reproduction"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Tejada, M., Santos-Llamas, A., Fern\u00e1ndez-Ram\u00edrez, M., Tar\u00edn, J., Cano, A., and G\u00f3mez, R. (2021). A Reassessment of the Therapeutic Potential of a Dopamine Receptor 2 Agonist (D2-AG) in Endometriosis by Comparison against a Standardized Antiangiogenic Treatment. Biomedicines, 9.","DOI":"10.3390\/biomedicines9030269"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1095\/biolreprod.110.084392","article-title":"Identification and Quantification of Dopamine Receptor 2 in Human Eutopic and Ectopic Endometrium: A Novel Molecular Target for Endometriosis Therapy1","volume":"83","author":"Carda","year":"2010","journal-title":"Biol. Reprod."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Shome, S., Dasgupta, P.S., and Basu, S. (2012). Dopamine Regulates Mobilization of Mesenchymal Stem Cells during Wound Angiogenesis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031682"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.7150\/jca.27780","article-title":"The Prospective Value of Dopamine Receptors on Bio-Behavior of Tumor","volume":"10","author":"Wang","year":"2019","journal-title":"J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/0192623308326151","article-title":"Nonclinical Safety Evaluation of Sunitinib: A Potent Inhibitor of VEGF, PDGF, KIT, FLT3, and RET Receptors","volume":"36","author":"Patyna","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1523\/JNEUROSCI.5074-06.2007","article-title":"Regulation of Akt Signaling by D2 and D3 Dopamine Receptors In Vivo","volume":"27","author":"Beaulieu","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnmol.2011.00038","article-title":"Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors","volume":"4","author":"Beaulieu","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-52528-4","article-title":"Dopamine D2 receptor modulates Wnt expression and control of cell proliferation","volume":"9","author":"Han","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.fertnstert.2012.06.029","article-title":"Pathogenesis and pathophysiology of endometriosis","volume":"98","author":"Burney","year":"2012","journal-title":"Fertil. Steril."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/3\/1775\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:14:01Z","timestamp":1760134441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/3\/1775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["ijms23031775"],"URL":"https:\/\/doi.org\/10.3390\/ijms23031775","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,4]]}}}